Bioteque Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jin-Long Lin

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.4yrs
Eigendom CEO	0.3%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	2.4yrs

Recente managementupdates

Recent updates

A Look At The Fair Value Of Bioteque Corporation (GTSM:4107)

Apr 26

Should You Buy Bioteque Corporation (GTSM:4107) For Its Dividend?

Mar 29

Bioteque Corporation's (GTSM:4107) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 11

Are Bioteque Corporation's (GTSM:4107) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Dec 10

Will Bioteque (GTSM:4107) Multiply In Value Going Forward?

Nov 22

Analyse CEO-vergoeding

Hoe is Jin-Long Lin's beloning veranderd ten opzichte van Bioteque's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	NT$501m
Mar 31 2024	n/a	n/a	NT$480m
Dec 31 2023	n/a	n/a	NT$453m
Sep 30 2023	n/a	n/a	NT$461m
Jun 30 2023	n/a	n/a	NT$449m
Mar 31 2023	n/a	n/a	NT$470m
Dec 31 2022	n/a	n/a	NT$494m
Sep 30 2022	n/a	n/a	NT$511m
Jun 30 2022	n/a	n/a	NT$466m
Mar 31 2022	n/a	n/a	NT$433m
Dec 31 2021	NT$5m	NT$2m	NT$431m
Sep 30 2021	n/a	n/a	NT$451m
Jun 30 2021	n/a	n/a	NT$483m
Mar 31 2021	n/a	n/a	NT$501m
Dec 31 2020	NT$5m	NT$2m	NT$489m
Sep 30 2020	n/a	n/a	NT$441m
Jun 30 2020	n/a	n/a	NT$433m
Mar 31 2020	n/a	n/a	NT$457m
Dec 31 2019	NT$5m	NT$2m	NT$464m

Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Jin-Long redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de TW markt.

Compensatie versus inkomsten: De vergoeding van Jin-Long is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Jin-Long Lin

2.4yrs

Tenure

NT$4,855,000

Compensatie

Mr. Jin-Long Lin served as a Director of Bioteque Corporation since June 24, 2013 until June 15, 2022 and serves as its Senior Vice President since March 30, 2005. He is General Manager of Bioteque Corpora...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yi-Xun Li	VP & Director	17.4yrs	NT$4.59m	1.07% NT$ 91.7m
Ming-Zhong Li	Chairman	27.8yrs	NT$11.65m	1.05% NT$ 89.6m
Jing-Yi Tsai	VP & Vice Chairman of the Board	5.4yrs	NT$5.00m	0.26% NT$ 22.1m
Bin-Xi Lin	Independent Director	6.4yrs	NT$341.00k	geen gegevens
Xing Wang	Supervisor & Representative Director	5.4yrs	NT$652.00k	0.33% NT$ 28.4m
Hsu-Yuan Li	Representative Director	2.4yrs	NT$652.00k	geen gegevens
Teng-Yao Hsiao	Independent Director	2.4yrs	NT$221.00k	geen gegevens
Wen-Chung Yeh	Representative Director	2.4yrs	geen gegevens	geen gegevens
Yao-Ren Ho	Director	2.4yrs	geen gegevens	0.16% NT$ 13.7m
Ming Yeh Cheng	Director	2.4yrs	geen gegevens	geen gegevens
Yiu-Cho Chin	Independent Director	1.4yrs	geen gegevens	geen gegevens
Hung-Ying Lee	Representative Director	1.8yrs	geen gegevens	geen gegevens

2.4yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 4107 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.4 jaar), wat duidt op een nieuw bestuur.

Bioteque Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Bioteque Corporation Announces Board Changes

Bioteque Corporation, Annual General Meeting, Jun 19, 2024

Bioteque Corporation Announces Chief Internal Auditor Changes

Bioteque Corporation Announces Executive Appointments

Bioteque Corporation Announces Executive Changes

Less than half of directors are independent

Recent updates

Bioteque Corporation to Report Q3, 2024 Results on Nov 07, 2024

Second quarter 2024 earnings released: EPS: NT$1.80 (vs NT$1.48 in 2Q 2023)

Bioteque Corporation to Report Q2, 2024 Results on Aug 07, 2024

Upcoming dividend of NT$4.50 per share

First quarter 2024 earnings released: EPS: NT$1.81 (vs NT$1.42 in 1Q 2023)

Bioteque Corporation Announces Cash Dividend, Payable on August 30, 2024

Bioteque Corporation to Report Q1, 2024 Results on May 09, 2024

Bioteque Corporation to Report Q1, 2024 Results on May 09, 2024

Bioteque Corporation Announces Board Changes

Full year 2023 earnings released: EPS: NT$6.53 (vs NT$7.12 in FY 2022)

Bioteque Corporation, Annual General Meeting, Jun 19, 2024

Third quarter 2023 earnings released: EPS: NT$2.11 (vs NT$1.93 in 3Q 2022)

Now 21% undervalued after recent price drop

Upcoming dividend of NT$4.50 per share at 4.2% yield

Bioteque Corporation Announces Chief Internal Auditor Changes

Now 20% undervalued

Bioteque Corporation Announces Executive Appointments

Full year 2022 earnings released: EPS: NT$7.12 (vs NT$6.22 in FY 2021)

Bioteque Corporation Announces Executive Changes

Third quarter 2022 earnings: EPS exceeds analyst expectations

Less than half of directors are independent

Third quarter 2022 earnings: EPS exceeds analyst expectations

Bioteque Corporation Announces Change of Vice Chairman

Bioteque Corporation Announces Resignation of Tang-Lung Hsu as Natural-Person Director

Upcoming dividend of NT$4.50 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations

Bioteque Corporation Appoints Yiu-Cho Chin as Member of the Fifth Term of Compensation Committee

Bioteque Corporation Announces Resignation of Ren-Fang Li as Independent Director

Bioteque Corporation Appoints Members of the Fifth Term of Compensation Committee

Bioteque Corporation Announces Board Changes

First quarter 2022 earnings released: EPS: NT$1.76 (vs NT$1.74 in 1Q 2021)

Less than half of directors are independent

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS NT$1.29 (vs NT$1.75 in 3Q 2020)

Upcoming dividend of NT$4.00 per share

Second quarter 2021 earnings released: EPS NT$1.31 (vs NT$1.56 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$1.74 (vs NT$1.57 in 1Q 2020)

A Look At The Fair Value Of Bioteque Corporation (GTSM:4107)

Should You Buy Bioteque Corporation (GTSM:4107) For Its Dividend?

Full year 2020 earnings released: EPS NT$7.05 (vs NT$6.70 in FY 2019)

Bioteque Corporation Approves Dividend Distribution of 2020 Profits

Bioteque Corporation's (GTSM:4107) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

New 90-day low: NT$125

The Trends At Bioteque (GTSM:4107) That You Should Know About

Update: Bioteque (GTSM:4107) Stock Gained 51% In The Last Three Years

New 90-day low: NT$126

Estimating The Intrinsic Value Of Bioteque Corporation (GTSM:4107)

Bioteque (GTSM:4107) Has A Rock Solid Balance Sheet

New 90-day low: NT$130

Does Bioteque Corporation (GTSM:4107) Have A Place In Your Dividend Portfolio?

Are Bioteque Corporation's (GTSM:4107) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Will Bioteque (GTSM:4107) Multiply In Value Going Forward?

Third quarter 2020 earnings released: EPS NT$1.75

Revenue misses expectations

New 90-day low: NT$132

New 90-day low - NT$133

First half earnings released

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd